메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Springer Science and Business Media LLC EMBO Molecular Medicine 16(9)
오류 신고하기
표지

검색

    초록·키워드

    Currently, over 350 million people worldwide live with chronic inflammatory diseases, facing a range of complications that severely impact their quality of life. Among these complications is amyloidosis, a group of diseases characterized by the extracellular deposition of insoluble amyloid fibrils that disrupt tissue structure and function. One specific form, amyloid A (AA) amyloidosis, is closely linked to chronic inflammatory conditions such as rheumatoid arthritis (RA), Familial Mediterranean Fever (FMF), Crohn’s disease, and chronic infections. In this issue of EMBO Mol Med, Losa et al, shows that the inflammasome adaptor ASC plays an important role in the pathogenesis of AA amyloidosis, and suggests a potential immunotherapy for treating the disease (Losa et al, 2024). S. Maasewerd and B. Franklin discuss a recent study by Aguzzi and colleagues (in this issue of EMBO Mol Med) that uncovers the important role played by the inflammasome adaptor ASC in the pathogenesis of AA amyloidosis.

    본문·목차

    최근 본 자료 전체보기